CS Paper Radar

CupOFMoCA: Coupled Objective-Guided Discrete Flows for Molecular Conjugate Assembly

Ruoxi Rosie Zhang, Ziang Li, Jiatao Gu, Pranam Chatterjee

cs.LG q-bio.BM ·submitted 2026-11-11 23:18 UTC · v1
top venue

Abstract

Molecular conjugates, including PROTACs and peptide-drug conjugates (PDCs), derive their function from the joint behavior of multiple coupled components, yet most generative approaches design these components independently and combine them only after generation. Such staged pipelines ignore cross-component dependencies and often produce conjugates that are chemically invalid, fall outside empirical conjugate distributions, or lose function upon assembly. In this work, we introduce Coupled Objective-Guided Discrete Flows for Molecular Conjugate Assembly (CupOFMoCA), a discrete generative method that enforces cross-component chemical constraints during conjugate generation. CupOFMoCA restricts guided updates to chemically feasible conjugate states and reweights local transitions using molecular design objectives. Across three PDC systems, coupled generation achieved 100% conjugation validity among valid peptides and increased valid yield over matched post-hoc filtering, with comparable predicted binding scores across the full valid sets. In three-seed evaluations of three PROTAC systems, CupOFMoCA achieved the highest assembly validity on two systems and generated more assembly-valid molecules per second than the evaluated baselines. We further evaluated the generated PROTACs with post-hoc DegradeMaster scoring and explicit-solvent molecular dynamics, supporting their predicted activity and conformational properties. Together, these results establish CupOFMoCA as an efficient generator of molecular conjugates, supporting therapeutic development via coordinated control of assembly and molecular properties.

Comment
Published at NeurIPS 2026. (Proceedings of the 40th Conference on Neural Information Processing Systems, Sydney, Australia)

Closest papers

Nearest neighbours by meaning across the whole index.

DC-Flow: Target-Conditioned Cyclic Peptide Design via Delayed-Coupling Flow Matching

cs.LG ·2026-10-11 ·Yitian Wang, Minjie Cheng, Yaning Cui, Maohua Yang, Dongdong Wang +1 more
code/data similarity 0.68
Abstract

Target-conditioned cyclic peptide design requires coordinating interfacial side chains with macrocyclic closure. Existing end-to-end generators concurrently update geometric and chemical variables from noise, assigning residues to disordered coordinates. Meanwhile, predictor-assisted workflows often get stuck in local traps because they lack feedback in the propose-and-filter stage and ignore 3D structural proposals during sequence search. To overcome the drawbacks of these two paradigms, we propose DC-FLOW, a staged generative framework built around Delayed-Coupling Flow Matching. In principle, DC-FLOW postpones sequence and side-chain activation until a target-conditioned backbone takes shape, resolving structural ambiguity before chemical assignment. Then, it feeds delayed activations back into the backbone, achieving co-evolution of backbone geometry and emerging residue identities by coupling their flows. This mechanism enables more reliable macrocyclic closure and favorable interface packing. For predictor-assisted workflows, DC-FLOW supplies 3D proposals with in-trajectory guidance, enabling cascaded test-time scaling to prune redundant backbones and terminate unpromising refinement early. Extensive experiments show that DC-FLOW improves cyclization fidelity, diversity, and interface energetics, substantially increasing the yield of confident cyclic peptide binders under a fixed final-candidate budget. Our code is available at https://github.com/mianqiu00/DCFlow.

0.26

Transferring Peptide-Target Interaction Patterns to Small Molecules by Joint Guidance for Diffusion and Flow Matching

cs.LG cs.AI ·2026-10-30 ·Jian Lee, Changyun Cho, Sun Kim
similarity 0.67
Abstract

Generating small molecules to target protein-protein interactions (PPIs) remains one of the most challenging yet high-reward frontiers in drug discovery. Unlike traditional small-molecule drugs that bind to deep, well-defined pockets, PPI interfaces often comprise broad, shallow binding surfaces. A natural strategy is to leverage known peptide-target interactions, as peptide ligands provide rich interface-level constraints. However, a major algorithmic challenge is that rigid atom-level conditioning on peptide structures can over-constrain the generative space and exclude valid small-molecule solutions. To address this challenge, we present PIFT (Peptide InterFace Transfer), a novel framework that transfers peptide-target interaction patterns to small molecules through joint sampling-time guidance of masked discrete diffusion and continuous flow matching. PIFT first maps peptide-target and small-molecule-target interfaces into a shared, target-conditioned interaction space, capturing transferable interface information across molecular modalities. The resulting peptide-derived reference then jointly steers building-block logits and 3D coordinates toward peptide-compatible molecules while preserving a strong adapted molecular prior. Extensive experiments across diverse PPI targets show that the learned representation captures cross-modal interaction compatibility, while peptide guidance improves interface recovery and achieves strong docking performance and favorable molecular properties.

0.18

pCoMole: Pareto-Constrained Molecule Editing with Discrete Flows

cs.LG q-bio.BM ·2026-10-01 ·Tong Chen, Maximilian Holsman, Lin Zhao, Pranam Chatterjee
top venue similarity 0.66
Abstract · Published at NeurIPS 2026. (Proceedings of the 40th Conference on Neural Information Processing Systems, Sydney, Australia)

Biomolecular therapeutics often start from known sequences and require targeted editing to improve multiple properties while satisfying hard biochemical and manufacturability constraints. However, existing generative methods do not jointly support multi-objective optimization, hard feasibility, and sequence editing in discrete, variable-length biological spaces. In this work, we introduce Pareto-Constrained Molecule Editing (pCoMole), a framework built on discrete flow matching that steers a pre-trained Edit Flow toward user-specified preferences while enforcing terminal feasibility. pCoMole defines a feasibility-gated terminal distribution using an augmented Tchebycheff utility and realizes the resulting preference tilt through a Doob-h transform of the underlying edit process. To make this construction practical, we approximate the required harmonic function using short Monte Carlo rollouts over candidate edits, yielding an efficient guided editor with provable preference consistency. We validate pCoMole by shrinking GFP while retaining fluorescence-related properties, shortening diverse Cas9 orthologs while preserving PAM specificity, and compressing peptide binders into short peptidomimetics that optimize seven drug-related properties under hard constraints. In wet lab testing, two 229-residue pCoMole-designed eGFP variants retained clear green fluorescence in BL21 cells after 10 deletions, with either one or two substitutions. Together, pCoMole enables constraint-aware, Pareto-aligned editing of biomolecular sequences in discrete, variable-length spaces.

0.36

Language-Informed Flow Matching for Trend-Guided Structure-Based 3D Molecular Generation

cs.LG ·2026-08-31 ·Tianyu Gao, Zhikai Su, Jiashu Li, Wenjun Gao, Zichuan Ying +3 more
top venuecode/data similarity 0.66
Abstract · Accepted at Findings of EMNLP 2026

Structure-based drug design (SBDD) requires ligands that satisfy both 3D target affinity and 1D chemical validity. Existing controllable generation methods often rely on task-specific fine-tuning or externally imposed sampling-time guidance, adding cost and potentially conflicting with evolving 3D geometric constraints. We propose LiFT, a language-informed cross-modal framework built on Flow Matching for trend-guided 3D molecular generation across both de novo design and scaffold hopping. LiFT uses a "Sense-Evolve-Assemble" agent to generate target-aware SMILES as intermediate chemical conditions, from which a pre-trained chemical foundation model extracts continuous semantic priors. These priors are integrated into geometric generation through a lightweight semantic projector with zero-initialized adaptive normalization for stable cross-modal conditioning. We further introduce a Self-Conditioned Decoupled Router (SCDR), which modulates the velocity field according to intermediate structural states during ODE integration. Experiments on Cross-Docked2020 show that LiFT achieves competitive distribution matching while improving medicinal chemistry metrics and maintaining competitive structural validity under task-steering settings without additional generator fine-tuning. Our results suggest that language-derived chemical priors provide effective trend-level guidance for 3D molecular generation. Code and released artifacts are available at https://github.com/kasurl/LiFT.

0.58

One Sequence, Many Decodings: CAGenMol-2 Recasts Drug Design as Masked Molecular Inference

cs.LG cs.AI ·2026-09-28 ·Yanting Li, Enyan Dai, Lei Wang, Wen-Cai Ye, Li Liu
similarity 0.63
Abstract

Drug design couples property evaluation, conditional generation, structure-based design, and local optimization, yet machine learning systems typically address these capabilities with separate task-specific models. We introduce CAGenMol-2, a masked diffusion molecular language model that represents molecules, continuous scalar properties, and 3D protein pockets within a single wrapped sequence. Within this pretrained interface, downstream operations are selected by which sequence regions are observed or masked at inference, allowing one checkpoint to perform property prediction, property- and pocket-conditioned generation, and partial-constraint design without task-specific architectures or backbone fine-tuning. We further propose Adaptive Fragment Optimization (AdaFO), a gradient-free mask-and-refill search that turns the masked decoder into an iterative local molecular optimizer. On CrossDocked2020, AdaFO increases Success Rate from 30.2\% to 70.8\%, the best reported under this protocol, while largely preserving drug-likeness and diversity. Finally, scaffold-preserving directional editing and CRBN/VHL case studies demonstrate its use in compound design workflows spanning local molecular editing, structure-based prioritization, and downstream simulation-based screening.

0.15

Navigating Route Latent Space for Synthesizable Molecular Design

cs.AI cs.CE ·2026-10-06 ·Tao Li, Tuan Vinh, Monika Raj, Yuan Fang, Zhichun Guo +1 more
position similarity 0.61
Abstract

Goal-directed molecular design has advanced rapidly, yet a substantial proportion of designed molecules remain difficult to synthesize in practice, limiting their real-world utility. Prior synthesizability-aware methods either project generated molecules back to synthesizable analogs that deviate from the intended target, or optimize directly in discrete synthesis spaces that lack a continuous landscape for efficient search. We argue that this limitation mainly comes from the search space rather than the optimizer. To address this, we propose RouteFlow, a framework that reformulates synthesizable molecular design as a search over a continuous route latent space, where each latent maps back to a complete synthesis route and synthesizability is inherently preserved. To navigate this space, we adopt reward-guided flow matching as an efficient sampler that steers toward high-property regions. Since reward optimization may push latents off the manifold of real synthesis routes, where decoding becomes unreliable, we further introduce a cycle-consistency mechanism to stabilize fine-tuning. Across 16 optimization tasks from Therapeutic Data Commons, RouteFlow achieves the best sample efficiency among synthesizability-aware baselines, with the best synthetic accessibility and the highest retrosynthesis success rate. Our results also confirm that the proposed cycle-consistency reliably keeps optimization on-manifold while improving target properties, supporting effective synthesizable molecular discovery.

0.17

FAR-DPO: Feasibility-Aware and Robust Direct Preference Optimization for Cyclic Peptide Design

cs.LG ·2026-08-20 ·Guofeng Zhang, Rong Han, Xiaoyu Wang, Zhiyun Li, Zongbo Han +2 more
benchmarkhot direction similarity 0.61
Abstract · 8 pages, 4 figures, 3 tables. Accepted at the AIPBDA workshop of IEEE BIBM 2026

Cyclic peptides are emerging as promising molecular scaffolds in drug discovery due to their high binding affinity and structural stability. However, extending generative models from linear to cyclic peptide design remains challenging, as cyclization sharply restricts the feasible design space through coupled geometric and biophysical constraints. Moreover, limited training data has led existing approaches to rely largely on zero-shot generation or post hoc filtering, resulting in low yields of feasible designs and limited control over multi-objective trade-offs. To address these limitations, we propose FAR-DPO (Feasibility-Aware and Robust Direct Preference Optimization), an architecture-agnostic framework that steers generative models toward structurally and biophysically feasible cyclic peptide designs, particularly for challenging targets. FAR-DPO integrates feasibility-aware preference construction with difficulty-aware group-robust optimization. Specifically, it constructs within-target preference pairs through feasibility-gated multi-objective dominance and adaptively reweights predefined difficulty groups according to their current preference losses. Under a fixed generation budget, FAR-DPO increases overall success rate on the CPSea benchmark from 46.9% to 57.8% on PepGLAD and from 48.0% to 49.6% on PepFlow. These gains also extend to the hardest target quartile and are accompanied by more favorable best-per-target binding scores. Together, these results demonstrate FAR-DPO's effectiveness in improving feasibility and target-wise robustness.

0.38

MolHop: Scaffold-Hopping Molecular Design with Agentic Reinforcement Learning

cs.LG cs.CL ·2026-10-14 ·Yanyi Su, Chenyan Wang, Yulei Gong, Yeyun Chen, Xiaohui Yang +1 more
similarity 0.61
Abstract · Under review at ICLR 2027

Molecular design is often formulated as an optimization problem over existing molecular spaces. However, molecular optimization and the discovery of structurally distinct replacement molecules represent two fundamentally different search problems. LLM-based molecular design agents typically perform the former, conducting local refinement within the neighborhood of existing structures to improve target properties through structural modifications. In contrast, the latter requires exploration of a broader chemical space to discover molecules with entirely different scaffolds while preserving the functional characteristics of reference molecules. We propose MolHop, an agentic framework for cross-scaffold molecular discovery that enables models to navigate and edit within a pre-organized chemical space. MolHop organizes approximately 1.6 million molecular scaffolds from commercial molecules into a coarse-to-fine hierarchical action space. The agent selects new exploration regions through scaffold navigation actions and adjusts candidate properties through molecular editing. The framework maintains historical trajectory memory to support long-horizon search processes. On drug molecule and commercial compound tasks, connecting Grok-4.6 and DeepSeek-Flash-V4.1 to the MolHop framework substantially improves their cross-scaffold joint success rates. We develop MolHop-9B through agentic reinforcement learning, and MolHop-9B outperforms generative baselines including GPT-5.6-sol, Claude-5-Opus, and Gemini-3.1-Pro, while generating candidate molecules with larger scaffold differences from the reference molecules. These results demonstrate that effective molecular discovery beyond the traditional optimization paradigm requires structured chemical and action spaces, enabling agents to explore new structural regions rather than merely refine existing molecules.

0.19